NadA, a novel vaccine candidate of Neisseria meningitidis

Journal of Experimental Medicine

Volumn 195, Issue 11, 2002, Pages 1445-1454

  Comanducci, Maurizio ^a   Bambini, Stefania ^a   Brunelli, Brunella ^a   Adu Bobie, Jeannette ^a   Aricò, Beatrice ^a   Capecchi, Barbara ^a   Giuliani, Marzia Monica ^a   Masignani, Vega ^a   Santini, Laura ^a   Savino, Silvana ^a   Granoff, Dan M ^b   Caugant, Dominique A ^c   Rappuoli, Rino ^a   Mora, Marirosa ^a  

^a CHIRON VACCINES   (Italy)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Adhesin; Meningococcus; N. meningitidis; Pathogenesis; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE; NADA ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL VIRULENCE; BINDING AFFINITY; CHEMICAL STRUCTURE; HOST CELL; MOLECULAR WEIGHT; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; BASE COMPOSITION; BASE SEQUENCE; BLOTTING, WESTERN; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; FLOW CYTOMETRY; GENE TRANSFER, HORIZONTAL; HUMANS; IMMUNE SERA; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MICE; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; RATS;

EID: 0037013966     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020407     Document Type: Article

References (45)

1. Development of meningococcal serogroups
2. Vaccines for prevention of meningococcal disease
3. Global epidemiology of meningococcal disease
4. Population genetics and molecular epidemiology of Neisseria meningitidis
5. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms
6. Human immunity to the meningococcus: Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
7. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers
8. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children
9. Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C
10. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
11. Meningococcal vaccines. Current status and future possibilities
12. The changing epidemiology of meningococcal disease in the United States, 1992-1996
13. Meningococcal disease in Europe: Epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000
14. Antibodies to polysialic acid and its N-propyl derivative: Binding properties and interaction with human embryonal brain glycopeptides
15. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues
16. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans
17. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The active bacterial core surveillance team
18. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998
19. Development of a meningococcal vaccine
20. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
21. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children
22. The virulence plasmid of Yersinia, an antihost genome
23. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
24. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491
25. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
26. Improvements in a secondary structure prediction method based on a search for local sequence homologies and its use as a building tool
27. Predicting coiled coils by use of pairwise residue correlations
28. Computational approaches to identify leucine zippers
29. High-level tetracycline resistance resulting from TetM in strains of Neisseria spp. Kingella denitrficans, and Eikenella corrodens
30. Molecular characterization of two β-lactamase-specifying plasmids isolated from Neisseria gonorrhoeae
31. Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities
32. Insertion of Tn916 in Neisseria meningitidis resulting in loss of group B capsular polysaccharide
33. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice
34. Differences in surface expression of NspA among Neisseria meningitidis group B strains
35. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein
36. A protective epitope of Moraxella catarrhalis is encoded by two different genes
37. Increased virulence of Yersinia pseudotuberculosis by two independent mutations
38. Analysis of the yopA gene encoding the Yop1 virulence determinants of Yersinia spp.
39. Role of the carboxy-terminal phenylalanine in the biogenesis of outer membrane protein PhoE of Escherichia coli K-12
40. DNA binding exerted by a bacterial gene regulator with an extensive coiled coiled domain
41. Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins
42. Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products
43. Site-specific insertion of IS 1301 and distribution in Neisseria meningitidis strains
44. Coiled coils: New structures and new functions
45. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil